Dr Shabana Parvez, MD FACEP
Google Ads Updates Healthcare Policy: Prescription Drug Terms Now Allowed in Limited, Non-Promotional Contexts: In a significant policy shift, Google Ads has announced updates to its healthcare and medicines advertising policy, allowing limited, contextual use of prescription drug terms in ads and landing pages. The update, effective October 29th, marks a step toward supporting public health awareness, education, and transparency in online advertising.
Previously, any ad referencing prescription drugs was automatically restricted, even if it aimed to educate rather than promote. Under the new rules, advertisers can now include prescription drug terms in non-promotional contexts—such as public health announcements, academic publications, or legal actions.
However, Google emphasized that the policy on keyword targeting remains unchanged. Advertisers in the U.S., Canada, and New Zealand must still obtain appropriate healthcare certification to target keywords containing prescription drug terms. This certification applies primarily to online pharmacies, telemedicine providers, and pharmaceutical manufacturers.
In all other regions, the promotion of prescription drugs remains strictly prohibited. Certified entities may only use drug-related terms for informational or educational purposes, and even then, only if local regulations allow.
The tech giant also clarified its approach to enforcement. Advertisers will now receive a seven-day warning before any account suspension related to violations of the updated policy, giving them time to adjust campaigns accordingly.
This change aligns with Google’s ongoing efforts to balance healthcare advertising safety with access to credible health information. By allowing limited, non-promotional use of prescription terms, Google aims to support responsible communication in the healthcare sector while maintaining its commitment to user safety and regulatory compliance.
